Drug development Process and R&D
New medicines lead to improved patient outcomes and societal benefits, but R&D is a long and costly process. Ongoing health economics research aims to find the right balance between incentivising manufacturers to innovate and ensuring affordable access for health systems.
- June 2022
Estimating the Impact of U.S. Drug Price-setting Policies on Innovation Is Challenging, Even for the Congressional Budget Office
- March 2022
Invest to End TB. Save Lives. World TB Day 2022. Reflections on 60 years of OHE publications on TB.
- Past Event
- Annual lecture
- September 2021
Virtual OHE Annual Lecture 2021: Do Patents Work? Evidence from Pharmaceutical Innovation
- July 2021
How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine? Where are we 6 Months on?
- March 2021
Does Government Funding Increase Public Sector Development of New Medicines?
- June 2020